PTEN and leukemia: Yilmaz et al. have demonstrated that rapamycin restored normal HSC function and effectively depleted leukemia-initiating cells simultaneously [67], suggesting that mTOR plays a significant role downstream of the PI3K/PTEN/AKT axis and can be an ideal therapeutic target.